Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: Therapeutic strategy for herpetic stromal keratitis

American Journal of Pathology

Volumn 165, Issue 6, 2004, Pages 2177-2185

  Kim, Bumseok ^a   Tang, Qingquan ^b   Biswas, Partha S ^a   Xu, Jun ^b   Schiffelers, Raymond M ^b   Xie, Frank Y ^b   Ansari, Aslam M ^b   Scaria, Puthupparampil V ^b   Woodle, Martin C ^b   Lu, Patrick ^b   Rouse, Barry T ^a,c  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Intradigm Corporation   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CPG ISLAND; DRUG EFFICACY; DRUG INHIBITION; FEMALE; GENE DELIVERY SYSTEM; GENE TARGETING; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SYSTEMIC THERAPY;

EID: 9644275599     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63267-1     Document Type: Article

References (28)

1. Deshpande SP, Zheng M, Lee S, Rouse BT: Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions. Vet Microbiol 2002, 86:17-26
2. Thomas J, Rouse BT: Immunopathogenesis of herpetic ocular disease. Immunol Res 1997, 16:375-386
3. Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT: Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol 2001, 75:9828-9835
4. Zheng M, Schwarz MA, Lee S, Kumaraguru U, Rouse BT: Control of stromal keratitis by inhibition of neovascularization. Am J Pathol 2001, 159:1021-1029
5. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM: CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 1996, 93:2879-2883
6. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549
7. Zheng M, Klinman DM, Gierynska M, Rouse BT: DNA containing CpG motifs induces angiogenesis. Proc Natl Acad Sci USA 2002, 99:8944-8949
8. Klinman DM, Zheng M, Gierynska M, Rouse BT: DNA containing bioactive CpG motifs promote angiogenesis. Drug News Perspect 2002, 15:358-363
9. Sioud M: Therapeutic siRNAs. Trends Pharmacol Sci 2004, 25:22-28
10. Verma UN, Surabhi RM, Schmaltieg A, Becerra C, Gaynor RB: Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 2003, 9:1291-1300
11. Sorensen DR, Leirdal M, Sioud M: Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003, 327:761-766
12. Lu PY, Xie FY, Woodle MC: siRNA-mediated antitumorigenesis for drug target validation and therapeutics. Curr Opin Mol Ther 2003, 5:225-234
13. Sanceau J, Truchet S, Bauvois B: Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. J Biol Chem 2003, 278:36537-36546
14. Tuschl T: RNA interference and small interfering RNAs. Chembiochem 2001, 2:239-245
15. Tuschl T: Expanding small RNA interference. Nat Biotechnol 2002, 20:446-448
16. Babu JS, Kanangat S, Rouse BT: Limitations and modifications of quantitative polymerase chain reaction. Application to measurement of multiple mRNAs present in small amounts of sample RNA. J Immunol Methods 1993, 165:207-216
17. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ: A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 1996, 37:1625-1632
18. Ramanathan M, Giladi A, Leibovich SJ: Regulation of vascular endothelial growth factor gene expression in murine macrophages by nitric oxide and hypoxia. Exp Biol Med (Maywood) 2003, 228:697-705
19. Autiero M, Luttun A, Tjwa M, Carmeliet P: Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 2003, 1:1356-1370
20. Bushman F: RNA interference: applications in vertebrates. Mol Ther 2003, 7:9-10
21. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498
22. Sioud M, Sorensen DR: Cationic liposome-mediated delivery of siR-NAs in adult mice. Biochem Biophys Res Commun 2003, 312:1220-1225
23. Ruoslahti E, Pierschbacher MD: New perspectives in cell adhesion: RGD and integrins. Science 1987, 238:491-497
24. Godbey WT, Wu KK, Mikos AG: Poly(ethylenimine) and its role in gene delivery. J Control Release 1999, 60:149-160
25. Collo G, Pepper MS: Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. J Cell Sci 1999, 112:569-578
26. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R: Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci USA 2003, 100:4766-4771
27. Lee S, Zheng M, Kim B, Rouse BT: Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 2002, 110:1105-1111
28. Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT: CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol 2004, 172:1237-1245